Published in J Immunol on April 01, 1984
Widespread and selective induction of major histocompatibility complex-determined antigens in vivo by gamma interferon. J Exp Med (1985) 2.34
Massive induction of donor-type class I and class II major histocompatibility complex antigens in rejecting cardiac allografts in the rat. J Exp Med (1985) 1.57
Dendritic cell-lymphoid cell aggregation and major histocompatibility antigen expression during rat cardiac allograft rejection. J Exp Med (1986) 1.32
Enhanced MHC class II expression in renal proximal tubules precedes loss of renal function in MRL/lpr mice with lupus nephritis. Am J Pathol (1989) 1.17
Induction of HLA-DR expression on human myoblasts with interferon-gamma. Am J Pathol (1990) 1.08
Immunohistological observations in rat kidney allografts after local steroid administration. J Exp Med (1987) 0.80
Dynamics of early histopathological changes in GVHD after busulphan/cyclophosphamide conditioning regimen. Int J Clin Exp Pathol (2011) 0.79
Expression of Ia antigens by murine kidney epithelium after exposure to streptozotocin. Am J Pathol (1987) 0.78
Graft-specific MHC class II gene expression in response to allogeneic stimulus in heterotopic murine cardiac allografts. Immunology (1992) 0.78
Histologic studies on the hepatic lesions induced by graft-versus-host reaction in MHC class II disparate hosts compared with primary biliary cirrhosis. Am J Pathol (1989) 0.77
The origin of Ia antigen-expressing cells in the rat kidney. Am J Pathol (1987) 0.75
The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02
Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant (2008) 8.09
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39
Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant (2011) 4.06
Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant (2009) 3.43
Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant (2010) 3.29
International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int (1993) 3.11
Tolerance versus immunosuppression: a perspective. Am J Transplant (2008) 2.71
Cloning of mouse myeloma cells and detection of rare variants. J Cell Physiol (1972) 2.63
Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant (2012) 2.28
Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant (2007) 2.25
De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant (2009) 2.24
Mutations in immunoglobulin-producing mouse myeloma cells. Science (1973) 1.94
FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes. Am J Transplant (2008) 1.94
A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. Am J Transplant (2012) 1.93
Role of antibody to S100 protein in diagnostic pathology. Am J Clin Pathol (1983) 1.80
Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. Am J Transplant (2010) 1.65
NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. Am J Transplant (2010) 1.62
The nature of biopsies with "borderline rejection" and prospects for eliminating this category. Am J Transplant (2011) 1.60
Ischemic acute tubular necrosis induces an extensive local cytokine response. Evidence for induction of interferon-gamma, transforming growth factor-beta 1, granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-10. Transplantation (1995) 1.59
Acute changes in renal function associated with deferoxamine therapy. Am J Dis Child (1989) 1.59
The 'two, one, zero' decision: what to do with suboptimal deceased donor kidneys. Am J Transplant (2010) 1.58
Molecular diagnosis of T cell-mediated rejection in human kidney transplant biopsies. Am J Transplant (2013) 1.57
Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours. Br J Cancer (1999) 1.55
The molecular phenotype of heart transplant biopsies: relationship to histopathological and clinical variables. Am J Transplant (2010) 1.54
Lies, damn lies, and statistics: the perils of the P value. Am J Transplant (2006) 1.50
The molecular landscape of antibody-mediated kidney transplant rejection: evidence for NK involvement through CD16a Fc receptors. Am J Transplant (2015) 1.48
Studies into the occurrence of soluble antigen--antibody complexes in disease. I. A biological assay for soluble complexes. Clin Exp Immunol (1968) 1.47
Studies into the occurrence of soluble antigen-antibody complexes in disease. 3. Rheumatoid arthritis and other human diseases. Clin Exp Immunol (1968) 1.45
Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant (2007) 1.44
The molecular phenotype of 6-week protocol biopsies from human renal allografts: reflections of prior injury but not future course. Am J Transplant (2010) 1.43
Pressure overload induces severe hypertrophy in mice treated with cyclosporine, an inhibitor of calcineurin. Circ Res (1999) 1.41
Renal failure after eating "magic" mushrooms. CMAJ (1992) 1.40
The "injury response": a concept linking nonspecific injury, acute rejection, and long-term transplant outcomes. Transplant Proc (1997) 1.39
Telomere shortening in kidneys with age. J Am Soc Nephrol (2000) 1.29
Differential localization within human kidney of five membrane proteins expressed on acute lymphoblastic leukemia cells. J Immunol (1986) 1.28
Delayed graft function in renal transplantation: etiology, management and long-term significance. J Urol (1996) 1.28
The regulation of expression of major histocompatibility complex products. Transplantation (1986) 1.27
Synthesis, assembly, and secretion of gamma globulin by mouse myeloma cells. 3. Assembly of the three subclasses of IgG. J Exp Med (1971) 1.27
Synthesis, assembly and secretion of gamma-globulin by mouse myeloma cells. V. Balanced and unbalanced synthesis of heavy and light chains by IgG-producing tumors and cell lines. J Immunol (1973) 1.26
Modification and fate of J chain in myeloma cells in the presence and absence of polymeric immunoglobulin secretion. Eur J Immunol (1978) 1.26
IFN-gamma alters the pathology of graft rejection: protection from early necrosis. J Immunol (2001) 1.25
Molecular diagnosis of antibody-mediated rejection in human kidney transplants. Am J Transplant (2013) 1.25
The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection. Transplantation (1990) 1.24
Immunoglobulin production and secretion by variant clones of the MOPC 315 mouse myeloma cell line. J Immunol (1980) 1.23
Immunohistochemical and electron microscopic assessment of childhood rhabdomyosarcoma. Increased frequency of diagnosis over routine histologic methods. Cancer (1983) 1.23
Scoring total inflammation is superior to the current Banff inflammation score in predicting outcome and the degree of molecular disturbance in renal allografts. Am J Transplant (2009) 1.21
Diagnosing rejection in renal transplants: a comparison of molecular- and histopathology-based approaches. Am J Transplant (2009) 1.19
Synthesis, assembly and secretion of mouse immunoglobulin. Transplant Rev (1973) 1.19
Salivary gland components involved in the formation of squamous metaplasia. Am J Pathol (1985) 1.18
Malignant myoepithelioma of the breast. An immunohistochemical study by light and electron microscopy. Cancer (1986) 1.18
Outer medullary circulatory defect in ischemic acute renal failure. Am J Pathol (1984) 1.16
Kidney transplants with progressing chronic diseases express high levels of acute kidney injury transcripts. Am J Transplant (2013) 1.16
Inflammation lesions in kidney transplant biopsies: association with survival is due to the underlying diseases. Am J Transplant (2011) 1.16
Focal segmental glomerulosclerosis and progressive renal failure associated with a unilateral kidney. Pediatrics (1984) 1.15
IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo. J Immunol (1997) 1.15
Studies into the occurrence of soluble antigen-antibody complexes in disease. II. Criteria for distinguishing soluble complexes from other macromolecular histamine releasers. Clin Exp Immunol (1968) 1.15
The transcriptome of the implant biopsy identifies donor kidneys at increased risk of delayed graft function. Am J Transplant (2007) 1.13
Microcirculation lesions alone are not reliable for identifying antibody-mediated rejection. Am J Transplant (2013) 1.13
The use of mycophenolate mofetil in transplant recipients. Immunopharmacology (2000) 1.13
Pathologic features of acute renal allograft rejection associated with donor-specific antibody, Analysis using the Banff grading schema. Transplantation (1996) 1.12
Synthesis but not secretion of J chain by variant mouse myeloma cells which lose alpha-chain-synthesizing ability. J Immunol (1975) 1.11
Origin of the desmoplasia in desmoplastic malignant melanoma. Hum Pathol (1983) 1.11
Comparing microarray versus RT-PCR assessment of renal allograft biopsies: similar performance despite different dynamic ranges. Am J Transplant (2008) 1.10
SWOT analysis of Banff: strengths, weaknesses, opportunities and threats of the international Banff consensus process and classification system for renal allograft pathology. Am J Transplant (2007) 1.10
Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse. Transplantation (1990) 1.09
Canine X chromosome-linked hereditary nephritis: a genetic model for human X-linked hereditary nephritis resulting from a single base mutation in the gene encoding the alpha 5 chain of collagen type IV. Proc Natl Acad Sci U S A (1994) 1.06
Cell senescence and its implications for nephrology. J Am Soc Nephrol (2001) 1.06
Interferon-gamma and donor MHC class I control alternative macrophage activation and activin expression in rejecting kidney allografts: a shift in the Th1-Th2 paradigm. Am J Transplant (2008) 1.06
Studies into the occurrence of soluble antigen-antibody complexes in disease. IV. Correlation between the rheumatoid biologically active factor and the clinical features of rheumatoid arthritis. Clin Exp Immunol (1969) 1.06
Interpreting NK cell transcripts versus T cell transcripts in renal transplant biopsies. Am J Transplant (2012) 1.06
Treatment of X-linked hereditary nephritis in Samoyed dogs with angiotensin converting enzyme (ACE) inhibitor. J Comp Pathol (1997) 1.05
Continued function of pancreatic islets after transplantation in type I diabetes. Lancet (1989) 1.05
Effects of donor age and cell senescence on kidney allograft survival. Am J Transplant (2009) 1.03
Changes in the transcriptome in allograft rejection: IFN-gamma-induced transcripts in mouse kidney allografts. Am J Transplant (2006) 1.03
Polyclonal gammopathy and lymphoproliferation after transfer factor in severe combined immunodeficiency disease. N Engl J Med (1973) 1.03
Molecular correlates of scarring in kidney transplants: the emergence of mast cell transcripts. Am J Transplant (2008) 1.02
Inhibition of MHC product induction may contribute to the immunosuppressive action of ciclosporin. Prog Allergy (1986) 1.01
The transcriptome of human cytotoxic T cells: measuring the burden of CTL-associated transcripts in human kidney transplants. Am J Transplant (2008) 1.01
The identification of mouse myeloma cells which have undergone mutations in immunoglobulin production. Soc Gen Physiol Ser (1974) 1.01
Myoepithelial cells in salivary gland tumors. An immunohistochemical study. Arch Pathol Lab Med (1985) 1.00
Interferon-gamma acts directly on rejecting renal allografts to prevent graft necrosis. Am J Pathol (2001) 1.00
Casein-induced murine amyloidosis: amyloidogenesis in vitro by monolayer spleen explants of casein-injected mice. Lab Invest (1978) 1.00
Monoclonal antibodies to an epithelial ovarian adenocarcinoma: distinctive reactivity with xenografts of the original tumor and a cultured cell line. Cancer Res (1986) 0.99
Cluster analysis of lesions in nonselected kidney transplant biopsies: microcirculation changes, tubulointerstitial inflammation and scarring. Am J Transplant (2010) 0.98
Salivary gland monomorphic adenoma. Ultrastructural, immunoperoxidase, and histogenetic aspects. Am J Pathol (1984) 0.98
Accelerated expression of senescence associated cell cycle inhibitor p16INK4A in kidneys with glomerular disease. Kidney Int (2006) 0.97
Correlation of renal histology with outcome in children with lupus nephritis. Kidney Int (1986) 0.96
Transcriptome analysis reveals heterogeneity in the injury response of kidney transplants. Am J Transplant (2007) 0.96
The role of donor-specific HLA alloantibodies in liver transplantation. Am J Transplant (2014) 0.96
Immunohistochemical localization of prekeratin filaments in benign and malignant cells in effusions. Comparison with intermediate filament distribution by electron microscopy. Am J Pathol (1982) 0.96
Protocol biopsies in renal transplantation: insights into patient management and pathogenesis. Am J Transplant (2007) 0.96
Time dependency of factors affecting renal allograft survival. J Am Soc Nephrol (2000) 0.95
Expression of B cell and immunoglobulin transcripts is a feature of inflammation in late allografts. Am J Transplant (2008) 0.95
Molecular landscape of T cell-mediated rejection in human kidney transplants: prominence of CTLA4 and PD ligands. Am J Transplant (2014) 0.94